Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 141 results found. Search for [ favipiravir ]

Results 1 to 21 of 141
PTI
May 4, 2021
Based on the criteria and principles laid out by the ministry, depending on each state's requirement, 24 different categories of items numbering nearly 40 lakhs were distributed to 38 institutions in different states


BusinessToday.In
May 4, 2021
Bajaj Healthcare Limited (BHL) has received approval from India's drug regulator, to manufacture and market 'Favijaj' in India for the treatment of COVID-19 from May 4, 2021, onwards


BusinessToday.In
New Delhi, May 3, 2021
A total of 122 crore doses of COVID-19 vaccines would be required to vaccinate the population of 59 crore in 18-45 years age group, the Centre has said; According to the preliminary data of state-owned fuel retailers, the second wave of coronavirus sweeping the nation has pummelled fuel sales in April as local restrictions clamped to curb the spread of infection stifled demand; The Centre may ask medical students, including final-year students of MBBS, to help India battle coronavirus crisis, as per government sources, amid a shortage of healthcare personnel as India battles the second wave of Covid-19. Watch this and more on News Blast.Also Read: 'Vaccine shortage may continue till July,' says Serum CEO Adar Poonawalla


Rashi Bisaria
New Delhi, May 3, 2021
India's fuel sales drop in April on local restrictions to curb second wave of COVID-19 According to the preliminary data of state-owned fuel retailers, the second wave of coronavirus sweeping the nation has pummelled fuel sales in April as local restrictions clamped to curb the spread of infection stifled demand. At the end of April, overall fuel demand is down by about 7 per cent from pre-Covid level of April 2019. COVID-19 vaccination: Centre says 122 cr doses needed to inoculate 59 cr ...


BusinessToday.In
May 2, 2021
The court said it has been informed by the Centre that NPPA has revised the maximum retail price of Remdesivir to Rs 3,500.


PTI
December 27, 2020
The vaccine development process by Bharat Biotech, Biological E Ltd and Aurobindo Pharma are currently in various stages, while Dr Reddy's and Hetero have tie ups for manufacturing the vaccine


BusinessToday.In
November 23, 2020
The study found that patients of confirmed COVID-19 with moderate symptoms were discharged from hospital earlier than those patients that did not receive Favipiravir, with the median time to clinical cure reduced by 2.5 days compared with the control group.


Niti Kiran
November 17, 2020
\"The strong growth for Glenmark, Cipla and Cadila can be attributed to COVID-19-related products such as favipiravir, remdesivir and tocilizumab,\" said a Nomura report


BusinessToday.In
November 7, 2020
Recently, Indian pharma companies are witnessing rampant cyber threats as they are delivering affordable medicines on a large scale amid the coronavirus pandemic


PB Jayakumar
November 3, 2020
Zydus today said it has filed an Investigational New Drug (IND) application for 'ZYIL1', an oral drug candidate, that has found to be effective in pre-clinic studies to control inflammation in COVID-19 related diseases


Chitranjan Kumar
October 28, 2020
Validated and approved by ICMR and the National Institute of Virology (NIV), Pune, Cipla's ELIfast is found to have specificity and sensitivity of 99.33 per cent and 92 per cent, respectively


Reuters
October 16, 2020
The company said last month a late-stage study of Avigan had shown reduced recovery times for COVID-19 patients with non-severe symptoms and it would seek to file for approval as early as this month


BusinessToday.In
October 14, 2020
SBI Cards stock touched a record high of Rs 895, rising 4.54% during the trading session today


Aseem Thapliyal
October 14, 2020
Jhunjhunwala increased stake in the company to 1.53 percent in Q2 from 1.47 percent in June quarter


PB Jayakumar
October 14, 2020
The indicated price is for treatment using the drug for about a month, or a treatment cycle depending on the disease progression and patient condition


PB Jayakumar
October 8, 2020
Cipla's research and development department is working on a couple of therapies that can be used in the treatment of COVID-19 and it could consider entering into marketing collaborations with companies that are currently developing vaccines for COVID-19


BusinessToday.In
New Delhi, October 8, 2020
Tata Consultancy Services has announced a salary hike for its employees effective October 1; The World Bank has warned that by 2021, as many as 150 million people are likely to be in extreme poverty because of the coronavirus pandemic; Chinese gaming app PUBG Mobile is reportedly talking to telecom major Bharti Airtel to bring the popular multiplayer game back on the mobile screens of its Indian fans. Watch this and more on News Blast.Also Read: Hetero plans to make COVID-19 drug Favipiravir in injection form


BusinessToday.In
October 8, 2020
Last month, Hetero became the first Indian drug company to launch Favipiravir in 800/200mg dosage for the treatment of mild-to-moderate symptomatic Covid-19 patients


BusinessToday.In
September 22, 2020
With the 800 mg of Favipiravir tablet, COVID-19 patients could undergo a more relaxed dosage, which will increase their compliance and experience


PB Jayakumar
September 21, 2020
The tech-driven platform that offers Continuous Medical Education (CME) and Continuing Professional Development (CPD) programmes for healthcare professionals, trained over 100,000 healthcare professionals over the last 6 months


PAGES 1 OF 8  12345